Back
Arcutis Biotherapeutics Vs. Zevra Therapeutics Industry Stock Comparison
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.39
Seasonality Move:
-24.31%
Sell
48
ZVRA
Zevra Therapeutics
Last Price:
7.84
Seasonality Move:
-17.07%
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.37. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $7.53. The Score for ZVRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.37
The current trend is moderately bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $7.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing selling pressure, which indicates risk of future bearish movement.
ARQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 52.77 | Buy |
| Chaikin Money Flow: | -959810 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.07 - 10.91) | Buy |
| Bollinger Bands (100): | (8.32 - 10.26) | Buy |
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 56.12 | Buy |
| Chaikin Money Flow: | -565862 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.09 - 7.57) | Buy |
| Bollinger Bands (100): | (4.58 - 6.98) | Buy |
ARQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.53 | Sell |
| 20-day SMA: | 10.23 | Buy |
| 50-day SMA: | 9.91 | Buy |
| 200-day SMA: | 8.11 | Buy |
| 8-day EMA: | 10.46 | Sell |
| 20-day EMA: | 10.27 | Buy |
| 50-day EMA: | 9.89 | Buy |
| 200-day EMA: | 8.94 | Buy |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.49 | Buy |
| 20-day SMA: | 7.39 | Buy |
| 50-day SMA: | 6.87 | Buy |
| 200-day SMA: | 5.73 | Buy |
| 8-day EMA: | 7.54 | Sell |
| 20-day EMA: | 7.35 | Buy |
| 50-day EMA: | 6.82 | Buy |
| 200-day EMA: | 5.83 | Buy |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.33 per share, and an increase next year of $1.08 per share.
Arcutis Biotherapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zevra Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||